RE: Real Estate Sale and Tax Lossesinstead of ignoring facts and making your schoolyard taunts that i'm the babbling one, why don't you take the time to actually read the sedar filings, particularly the recent sale on March 15, 2007 for $6m of 78% of the subsidiary (which resulted in the dilution gain of $4.5m)
in your mind, who organized these transactions? and why did outside investors lay out that money? fitch (the previous CFO) clearly knows how to capitalize on accounting structure and tax value, and that is why ID has now put him in the CEO position
and even though you think they are valueless, you shamelessly assert that you're "sure some of the tax losses will be expiring too". yet if you actually read the filings you would learn that at year-end 2006 they had:
--- $155m consolidated non-capital losses (nucryst 37)
--- $139m unclaimed scientific r&d expenditures (nucryst 7)
--- $20m consolidated capital losses of (nucryst 2)
--- $52m research and development tax credits (nucryst 4)
and that the expiry timing is not imminent
"The non-capital losses and research and development tax credits will expire at various times up to the end of 2026."